VULVAR CANCER
Clinical trials for VULVAR CANCER explained in plain language.
Never miss a new study
Get alerted when new VULVAR CANCER trials appear
Sign up with your email to follow new studies for VULVAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Hard-to-Treat vulvar cancer
Disease control OngoingThis study tests whether combining standard chemotherapy (cisplatin) and radiation with an immunotherapy drug (pembrolizumab) can shrink or control advanced vulvar cancer that cannot be removed by surgery. The trial includes 24 adults with unresectable, recurrent, or metastatic v…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hope for advanced cancers: immunotherapy drug shows promise
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with various advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink or control the tumors. Participants receive pembrolizumab and are monitored for tumor respons…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New triple therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of three drugs (entinostat, PDS01ADC, and bintrafusp alfa) in adults with advanced cancers linked to HPV or certain colon cancers that haven't responded to standard treatments. The goal is to find a safe dose and see if the combo can shrink tumors. …
Matched conditions: VULVAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 01, 2026 17:53 UTC
-
New imaging technique could improve lymph node detection in vulvar cancer
Diagnosis OngoingThis study compares a newer imaging method using indocyanine green (ICG) with the standard method (lymphoscintigraphy) to find sentinel lymph nodes in people with early-stage vulvar cancer. About 22 participants will receive both imaging types during their planned surgery. The go…
Matched conditions: VULVAR CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 17, 2026 02:57 UTC
-
New program aims to slash cancer wait times in botswana communities
Knowledge-focused OngoingThis study tests whether a program called Potlako+ helps people with cancer symptoms get diagnosed and treated faster. The program includes community education, support for healthcare workers, and patient guides. About 874 adults in Botswana will take part, with some communities …
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 17, 2026 02:57 UTC
-
Mid-Treatment PET scans could Fine-Tune radiation for tough cancers
Knowledge-focused OngoingThis study looks at whether doing a PET scan during radiation therapy can help doctors adjust the treatment plan for better results. It includes 90 adults with cervical, vulvar, esophageal, or anal canal cancers. The goal is to see if early imaging can predict how well the cancer…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Blood test may tame Chemo's nerve damage
Knowledge-focused TerminatedThis study looks at whether doctors can consistently measure the chemotherapy drug paclitaxel in the blood of cancer patients. The goal is to see if adjusting the dose based on these levels could reduce nerve damage, a common and severe side effect. About 22 adults with various s…
Matched conditions: VULVAR CANCER
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:03 UTC